Manufacturer record
Pristine Life Sciences: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Pristine Life Sciences (Sikkim) was declared Not of Standard Quality in June 2021. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PR/A-54, REMDESIVIR FOR INJECTION 100 mg/vial (COVIPRI INJECTION) (exp Nov 2022). RDTL Chandigarh (state lab) found it not of standard quality: Identification of Remdesivir, Particulate matter, Sterility. Listed in the June 2021 alert.
Records by type
1 record linked to Pristine Life Sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| REMDESIVIR FOR INJECTION 100 mg/vial (COVIPRI INJECTION) | Batch PR/A-54Mfg Dec 2020 · Exp Nov 2022 | Identification of Remdesivir, Particulate matter, SterilityIdentification | RDTL ChandigarhState lab | Jun 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.